	Machine Learning, Radiomics, and Clinical Models Predicting Checkpoint Inhibitor Pneumonitis in Lung Cancer: A Systematic Review and Meta-analysis. J Vis Exp He F, Liu G, Ye H, Ji F, Sun P, Xu Z. PMID: 42872743 [PubMed - indexed for MEDLINE]
	A plain language summary of the 7-year results from the CROWN study: lorlatinib compared with crizotinib in people with ALK-positive non-small cell lung cancer. Future Oncol Shaw AT, Solomon BJ, Felip E, Bauer TM, Liu G, Goto Y, Wu YL, Soo RA, Mazières J, Kim DW, Montague D, Pronsati N, Wang IM, Paolini J, Polli A, Rifi N, Al-Hashimi A, Toffalorio F, Mok TSK. PMID: 42872552 [PubMed - as supplied by publisher]
	Real-World Experience With Multimodal Treatment of Resectable Stage II-III Non-Small Cell Lung Cancer: A Single Institutional Analysis. Int J Cancer Griffo R, Niedermaier B, Klotz LV, Schneider M, Allgäuer M, Kriegsmann M, Roesch RM, Brendel L, Deissner H, Bozorgmehr F, Christopoulos P, Thomas M, Winter H, Eichhorn ME, Eichhorn F. PMID: 42872517 [PubMed - as supplied by publisher]
	The association between cirrhosis and outcomes among patients with lung cancer in Ontario between 2007 and 2017: A population-based study. Can Liver J Ho AK, Djerboua M, Chung W, Robinson A, Flemming JA. PMID: 42871941 [PubMed]
	An [18F]-FDG PET/CT Image Dataset for Artificial Intelligence-Based Classification of Lung Cancer. J Biomed Phys Eng Karimpour M, Mehdizadeh A, Alavi M, Mahmoudi T. PMID: 42871692 [PubMed]
	Context-dependent value of HLA class I diversity in advanced non-small cell lung cancer treated with immune checkpoint blockade. Front Immunol Ramos-Paradas J, Carrizo N, Álvarez E, Martín-Arriscado C, López M, Ortiz N, Herrera M, Rey M, Baena J, Zugazagoitia J, Paz-Ares L, Ucero ÁC. PMID: 42871323 [PubMed - indexed for MEDLINE]
	Serum NLRP3 levels are associated with postoperative delirium of elderly patients with lung cancer: an observational analytical study. Front Neurol Cheng Y, Liu Y, Tan G, Huang M, Wu X, Chen X. PMID: 42871060 [PubMed - indexed for MEDLINE]
	Regional disparities in lung cancer surgery and survival in South Korea: a nationwide population-based retrospective cohort study using linked cancer registry and national health insurance data. Transl Lung Cancer Res Kim HS, Yeob KE, Kim SY, Han HS, Park JH. PMID: 42870884 [PubMed]
	Prognostic impact of immune-related adverse events in non-completers of durvalumab consolidation therapy for non-small cell lung cancer: a single-center retrospective cohort study. Transl Lung Cancer Res Ebi N, Kawabata R, Fujimoto M, Hirata A, Sakaki Y, Otsuka Y, Kinoshita E, Shundo Y, Yanagihara T, Inoue H, Fujita M. PMID: 42870864 [PubMed]
	Vietnamese expert consensus on the diagnosis and multidisciplinary management of resectable non-small cell lung cancer. Transl Lung Cancer Res Do QK, Pham DX, Nguyen HTT, Binh NH, Nguyen KT, Lam TQ, Truong TT, Trinh DT, Le DT, Le AT, Le HT, Nguyen DTN. PMID: 42870861 [PubMed]
	Efficacy and safety of osimertinib combined with anlotinib in EGFR-mutant non-squamous non-small cell lung cancer with gradual progression after first-line osimertinib therapy: a single-center retrospective cohort study. Transl Lung Cancer Res Hao L, Yu H, Wang Y, Pan Y, Han X. PMID: 42870856 [PubMed]
	Plasma proteomic profiles associated with low-dose computed tomography findings and incident lung cancer: a prospective pilot study. Transl Lung Cancer Res Tikkanen A, Iivanainen S, Luukkainen MEK, Koivunen JP. PMID: 42870850 [PubMed]
	Efficacy and safety of third-generation EGFR-TKI rechallenge therapy in advanced non-small cell lung cancer patients with EGFR mutation: a retrospective cohort study. Transl Lung Cancer Res Sun J, Li X, Wang B, Chen Z, Yao Y, Wu R, Pan X, Xu X, Si Y, Liu H. PMID: 42870834 [PubMed]
	Efficacy and safety of antibody-drug conjugates in advanced small cell lung cancer: a systematic review and single-arm meta-analysis of prospective clinical trials. Transl Cancer Res Zhang P, Zhao W, Ma J, Li Y, Peng H, Jiang J. PMID: 42870825 [PubMed]
	Exploratory study to evaluate the combined effect of CBM588: Clostridium butyricum in platinum plus pemetrexed with pembrolizumab for non-small cell lung cancer-protocol of MIYABRO study. Transl Lung Cancer Res Tagawa R, Taniguchi H, Kaku N, Akagi K, Tomono H, Honda N, Dotsu Y, Matsuo M, Takemoto S, Itagaki A, Yamashita K, Umeyama Y, Gyotoku H, Ikeda T, Sugasaki N, Yoshiyama K, Kitazaki T, Nakatomi K, Takao D, Fukuda M, Yanagihara K, Mukae H. PMID: 42870820 [PubMed]
	Amivantamab plus chemotherapy vs. chemotherapy in participants with EGFR-mutant advanced non-small cell lung cancer after progression on osimertinib: a MARIPOSA-2 analysis of the Asian subgroup. Transl Lung Cancer Res Shih JY, Wang J, Wang Y, Wang J, Lee SH, Azuma K, Takahashi T, Tan JL, Lin CC, Ganguly S, Lee VH, Turna ZH, Sharma R, Kim YJ, Chu PL, Shah S, Diorio B, Cho BC. PMID: 42870814 [PubMed]
	Adjuvant alectinib versus crizotinib in completely resected ALK-positive non-small-cell lung cancer: a real-world retrospective cohort study. Transl Lung Cancer Res Yang Y, Liang S, Liu R, Tian J, Luo X, Ma G. PMID: 42870811 [PubMed]
	Deferring or delivering stereotactic radiosurgery in EGFR-mutated non-small cell lung cancer: lessons from the STARLET randomized analysis. Transl Lung Cancer Res Sheehan JP, Chung JH, Mantziaris G, Penberthy DR, Fadul CE. PMID: 42870805 [PubMed]
	A novel three-CpG signature for lung adenocarcinoma diagnosis: integrating multi-omics, machine learning, and clinical validation. Transl Cancer Res Liu Q, Shen M, Yan L, Li Y, Wang Y, Li J, Xiong S, Liao J, Li W, Xiong Y, Chen JC. PMID: 42870801 [PubMed]
	Clinical Value of SHOX2 and RASSF1A Methylation Combination in BALF Samples for the Diagnosis of Lung Cancer. J Environ Pathol Toxicol Oncol Zeng S, He X, Tan Y, He Z, Huang Y. PMID: 42870609 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 163777

Page 1 of 8189



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy